Victory Capital Management
ADVM

Victory Capital Management’s Adverum Biotechnologies ADVM Stock Holding History

Victory Capital Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,017
Closed -$7.29K – 2514
2023
Q1 		$7.29K Sell
1,017
-9
-0.9% -$64 ﹤0.01% 2565
2022
Q4 		$5.95K Hold
1,026
– – ﹤0.01% 2563
2022
Q3 		$10K Sell
1,026
-43
-4% -$565 ﹤0.01% 2658
2022
Q2 		$13K Sell
1,069
-69
-6% -$723 ﹤0.01% 2637
2022
Q1 		$12K Sell
1,138
-33
-3% -$483 ﹤0.01% 2667
2021
Q4 		$21K Sell
1,171
-21
-2% -$420 ﹤0.01% 2690
2021
Q3 		$26K Sell
1,192
-58
-5% -$1.48K ﹤0.01% 2719
2021
Q2 		$44K Sell
1,250
-9,544
-88% -$514K ﹤0.01% 2672
2021
Q1 		$1.06M Sell
10,794
-445
-4% -$53.4K ﹤0.01% 1885
2020
Q4 		$1.22M Sell
11,239
-1,678
-13% -$208K ﹤0.01% 1702
2020
Q3 		$1.33M Sell
12,917
-170
-1% -$25.5K ﹤0.01% 1584
2020
Q2 		$2.73M Sell
13,087
-145,477
-92% -$25.8M ﹤0.01% 1333
2020
Q1 		$15.5M Buy
158,564
+76,476
+93% +$8.92M 0.01% 961
2019
Q4 		$9.46M Buy
82,088
+25,028
+44% +$2.21M 0.01% 1028
2019
Q3 		$3.11M Buy
57,060
+37,570
+193% +$4.23M ﹤0.01% 1314
2019
Q2 		$2.32M Sell
19,490
-1,211
-6% -$100K ﹤0.01% 1102
2019
Q1 		$1.08M Sell
20,701
-233
-1% -$9.42K ﹤0.01% 1233
2018
Q4 		$659K Buy
20,934
+6,264
+43% +$255K ﹤0.01% 1301
2018
Q3 		$888K Sell
14,670
-804
-5% -$45.2K ﹤0.01% 1300
2018
Q2 		$820K Sell
15,474
-884
-5% -$53.2K ﹤0.01% 1290
2018
Q1 		$949K Buy
+16,358
New +$1.02M ﹤0.01% 1253

Other funds holding ADVM

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return

Victory Capital Management's ADVM Position: Q2 2023 in Review

Victory Capital Management sold out of Adverum Biotechnologies (ADVM) in Q2 2023, closing a stake of 1,017 shares — an estimated $7.29K sold.

Victory Capital Management first reported a position in ADVM in Q1 2018 and held it in 21 quarters. The position peaked at $15.5M in Q1 2020. 57 funds tracked by Wall St. Rank hold ADVM as of Q2 2023.

  • Victory Capital Management reported no remaining Adverum Biotechnologies position as of Q2 2023 after selling out during the quarter.
  • Victory Capital Management sold 1,017 Adverum Biotechnologies shares in Q2 2023, an estimated $7.29K.
  • Victory Capital Management first reported a position in Adverum Biotechnologies in Q1 2018 and held it in 21 quarters.
  • Victory Capital Management's Adverum Biotechnologies position peaked at $15.5M in Q1 2020.
  • 57 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2023.

Based on Victory Capital Management's 13F filing for Q2 2023, filed 27 Jul 2023.